1. Long‐term efficacy (up to 68 weeks) of Baricitinib in combination with topical corticosteroids in adult patients with moderate‐to‐severe atopic dermatitis: Analysis of treatment responders, partial responders and nonresponders originating from study BREEZE‐AD7. (20th January 2023) Authors: Silverberg, Jonathan I.; Simpson, Eric L.; Thyssen, Jacob Pontoppidan; Werfel, Thomas; Cardillo, Tracy E.; Colvin, Stephanie; Pierce, Evangeline; Chen, Yun‐Fei; Chen, Sherry; Eichenfield, Lawrence Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 37:Number 5(2023) Page Start: 1036 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗